(NASDAQ: DWTX) Dogwood Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.
Dogwood Therapeutics's earnings in 2025 is -$12,863,829.On average, 1 Wall Street analyst forecast DWTX's earnings for 2025 to be -$7,740,068, with the lowest DWTX earnings forecast at -$7,740,068, and the highest DWTX earnings forecast at -$7,740,068. On average, 1 Wall Street analyst forecast DWTX's earnings for 2026 to be -$5,484,937, with the lowest DWTX earnings forecast at -$5,484,937, and the highest DWTX earnings forecast at -$5,484,937.
In 2027, DWTX is forecast to generate -$4,452,928 in earnings, with the lowest earnings forecast at -$4,452,928 and the highest earnings forecast at -$4,452,928.